Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention.
|
21885812 |
2011 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Furthermore, transient transfection of an APC segment encoding amino acids 2140-2421 into a colon cancer cell line with mutant APC prevents cell cycle progression into or through S phase.
|
18474248 |
2008 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Relationship between the role of the adenomatous polyposis coli protein in colon cancer and its contribution to cytoskeletal regulation.
|
16042576 |
2005 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer.
|
21532750 |
2011 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The APC gene on chromosome 5 causing adenomatous polyposis coli represents a minority of the inherited colon cancer cases, while hereditary-non polyposis colon cancer (HNPCC) may cause five percent of all human colon cancer.
|
7903889 |
1993 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Colon cancer. Molecular biology of the APC protein.
|
9296069 |
1997 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In order to assess whether chronic infection with T. muris does indeed influence the development of cancer hallmarks, both wild type mice and colon cancer model (APC min/+) mice were infected with this parasite.
|
28650985 |
2017 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We studied the effect of C(2)-ceramide and C(2)-dihydroceramide on proliferation and/or apoptosis of colon cancer cell lines in vitro and determined the role of p53 and APC proteins in these processes.
|
15340841 |
2004 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
It is important to evaluate the effects of proposed interventions to reduce the risk of disease among carriers of a highly penetrant mutation, such as the mutations in BRCA1 and BRCA2 for breast and ovarian cancers or in APC and MLH1 or MSH2 for colon cancer.
|
15316055 |
2004 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Protein interactions of FAM134B with EB1 and APC/beta-catenin in vitro in colon carcinoma.
|
29964340 |
2018 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study concluded that rectal cancer may involve more nuclear beta-catenin in the APC/beta-catenin pathway than colon cancer and/or nuclear beta-catenin may have another role in rectal cancer independently of APC.
|
11592095 |
2001 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Deletion analysis indicated that the N-terminal region of the APC protein mediated its junctional localisation, consistent with our observation that truncated APC proteins in colon cancer cell lines are still capable of localising to the cell cortex.
|
16423286 |
2006 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Three APC isoforms that differ in their amino-terminal domains were evaluated by gene transfer experiments using a colon cancer cell line that lacks functional APC.
|
15273719 |
2004 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
HGUE-C-1 represents a novel and peculiar colon carcinoma model to study chemoresistance to chemotherapeutic agents and to novel anti-neoplasic drugs that interrupt signalling pathways such as the APC/βcatenin, Ras/Raf/Mek/Erk, PI3K/mTOR/p70S6K pathways as well as histone regulation mechanisms.
|
25885658 |
2015 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In a series of 11 microsatellite stable (MSS) and 9 microsatellite unstable (MSI) colon cancer cell lines and primary colon carcinomas (25 MSS and 28 MSI) with known ploidy stem line and APC, KRAS, and TP53 mutation status, we analyzed the promoter methylation of the following genes: hMLH1, MGMT, p16INK4a (CDKN2A alpha-transcript), p14ARF (CDKN2A beta-transcript), APC, and E-cadherin (CDH1).
|
15476557 |
2004 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Peptide-mediated precipitation experiments showed that anti-APCp1 bound and sequestered wild-type and mutant APC proteins in extracts of human colon cancer cell lines.
|
9663391 |
1998 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The APC/MCC gene (Familial Adenomatous Polyposis) at 5q21 plays a role in colon cancer carcinogenesis.
|
9182290 |
1996 |
Colon Carcinoma
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
The correlation between the methylation of APC gene and pathological parameters of colon cancer patients was analyzed.
|
28781669 |
2017 |
Colon Carcinoma
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
Expression of p16(INK4A) and APC genes is regulated by DNA methylation in three human colon cancer cell lines.
|
12970888 |
2003 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
APC, a negative regulator of Wnt signaling, decreased SF1-mediated activation of the MISRII promoter in the colon carcinoma cell line SW480.
|
12724325 |
2003 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The effect of doxorubicin and flavonoid extract on colon cancer HT-29 cell line death and identification of APC gene expression and PARP concentration of HT-29 cell line were investigated.
|
27064876 |
2016 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Here, we report that the expression status of adenomatous polyposis coli (APC) protein determines the relative sensitivity of colon cancer cells to HDAC inhibitor-induced apoptosis.
|
16982769 |
2006 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer.
|
11751382 |
2001 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We further showed that the colon cancer cell line expressing the wild-type APC gene was more sensitive to a DNA-methylating agent due to decreased DNA repair by long patch BER than the cell line expressing the mutant APC gene lacking the proliferating cell nuclear antigen-interacting protein-like box.
|
15548520 |
2005 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Among 10 FZD gene family members, FZD7 mRNA was predominantly expressed in six colon cancer cell lines with APC or CTNNB1 mutation.
|
18592008 |
2008 |